Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 886982 NEW YORK, NY
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$207,658,650
+$62,292,152 QoQ
Shares Held
6,129,240
+27.0% QoQ
Ownership
0.526%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Dec 31, 2025
CallValue
$105,798,779
CallShares
3,389,900
PutValue
$66,786,279
PutShares
2,139,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (10.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,199,799 $229,937,554
2 VTRS
Viatris Inc
 13,564,872 $215,410,166
3 TEVA
Teva Pharmaceutical Industries Ltd
This page 		6,129,240 $207,658,650
4 HIMS
Hims & Hers Health, Inc.
 5,173,865 $179,377,897
5 NBIX
Neurocrine Biosciences Inc
 631,892 $106,499,075
6 ALKS
Alkermes plc.
 2,023,984 $106,056,760
7 LNTH
Lantheus Holdings, Inc.
 814,096 $90,315,809
8 UTHR
UNITED THERAPEUTICS Corp
 165,979 $89,932,399

All Filings in TEVA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $207,658,650 6,129,240
2026-03-31 $145,366,498 4,826,245
2025-12-31 $66,786,279 2,139,900
2025-12-31 $105,798,779 3,389,900
2025-12-31 $183,454,469 5,878,067
2025-09-30 $102,729,502 5,085,619
2025-09-30 $68,118,440 3,372,200
2025-09-30 $24,035,980 1,189,900
2025-06-30 $81,835,626 4,882,794
2025-06-30 $44,244,724 2,639,900
2025-06-30 $2,344,724 139,900
2025-03-31 $60,945,999 3,965,257
2025-03-31 $2,150,263 139,900
2025-03-31 $96,391,418 6,271,400
2024-12-31 $55,686,264 2,526,600
2024-12-31 $10,513,080 477,000
2024-12-31 $77,511,130 3,516,839
2024-09-30 $74,933,069 4,158,328
2024-09-30 $59,019,104 3,275,200
2024-09-30 $2,162,400 120,000
2024-06-30 $56,472,000 3,475,200
2024-06-30 $69,723,013 4,290,647
2024-03-31 $50,003,863 3,543,860
2023-12-31 $39,727,831 3,805,348
2023-12-31 $8,846,856 847,400
2023-12-31 $24,069,420 2,305,500
2023-09-30 $31,267,080 3,065,400
2023-09-30 $13,233,480 1,297,400
2023-09-30 $45,280,788 4,439,293
2023-06-30 $34,260,241 4,549,833
2023-06-30 $9,769,422 1,297,400
2023-06-30 $23,082,462 3,065,400
2023-03-31 $11,481,990 1,297,400
2023-03-31 $26,810,190 3,029,400
2023-03-31 $41,197,730 4,655,111
2022-12-31 $14,007,408 1,535,900
2022-12-31 $34,742,640 3,809,500
2022-12-31 $48,683,871 5,338,144
2022-09-30 $42,118,660 5,219,165
2022-09-30 $12,394,713 1,535,900
2022-09-30 $30,742,665 3,809,500
2022-06-30 $11,549,968 1,535,900
2022-06-30 $36,238,638 4,818,968
2022-06-30 $33,375,264 4,438,200
2022-03-31 $14,422,101 1,535,900
2022-03-31 $31,865,668 3,393,575
2022-03-31 $37,177,827 3,959,300
2021-12-31 $32,116,095 4,009,500
2021-12-31 $12,302,559 1,535,900
2021-12-31 $32,834,383 4,099,174